In summary, we confirm prior reports that GABRA2 genotype and haplotype is associated with AD, as well as other types of substance use disorders. We also demonstrate that the effects are sex dependent and strongly suggest collaborative efforts to define the exact nature of the causal genetic variation are in order.
